DI BELLA METHOD > DOCUMENTATION INDEX > SCIENTIFIC WORKS

 
 
SCIENTIFIC WORKS
 
 
Monitoring intracellular melatonin levels in human prostate normal and cancer cells by HPLC. (06/05/2011)
Detail
Melatonin and doxorubicin synergistically induce cell apoptosis in human hepatoma cell lines. (06/05/2011)
Detail
Measuring serum melatonin in epidemiologic studies. (06/05/2011)
Detail
Inhibitory effects of melatonin on sulfatase and 17beta-hydroxysteroid dehydrogenase activity and expression in glioma cells. (06/05/2011)
Detail
Urinary 6-Sulphatoxymelatonin levels and risk of breast cancer in premenopausal women: the ORDET cohort. (06/05/2011)
Detail
Beneficial effects of melatonin on nicotine-induced vasculopathy. (06/05/2011)
Detail
Antioxidant enzymatically modified isoquercitrin or melatonin supplementation reduces oxidative stress-mediated hepatocellular tumor promotion of oxfendazole in rats. (06/05/2011)
Detail
Synergistic antitumor effect of melatonin with several chemotherapeutic drugs on human Ewing sarcoma cancer cells: potentiation of the extrinsic apoptotic pathway. (06/05/2011)
Detail
Sirtuins, melatonin and circadian rhythms: building a bridge between aging and cancer. (06/05/2011)
Detail
Inhibition of procarcinogen-bioactivating human CYP1A1, CYP1A2 and CYP1B1 enzymes by melatonin. (06/05/2011)
Detail
Signal transduction of the melatonin receptor MT1 is disrupted in breast cancer cells by electromagnetic fields. (06/05/2011)
Detail
The expression of MT1 melatonin receptor and Ki-67 antigen in melanoma malignum. (06/05/2011)
Detail
MT1 melatonin receptors and their role in the oncostatic action of melatonin (06/05/2011)
Detail
Actual and potential agents and biomarkers in the treatment of cancer. (06/05/2011)
Detail
Membrane-bound melatonin receptor MT1 down-regulates estrogen responsive genes in breast cancer cells. (06/05/2011)
Detail
 
 
 
Scorri con le frecce per visualizzare le pagine della ricerca 1 | 2 | 3 | 4 | 5 | 6 | 7 | 8 | 9 |
 
 

Stampa